UNLEASHING THE POWER OF RESEARCH
Exploring new frontiers in glioblastoma research to overcome challenges for patients worldwide
About Glioblastoma Research Society
Our Vision
The Glioblastoma Research Society envisions a world where scientific knowledge and medical innovation are accessible to all and have the potential to transform lives. We are committed to advancing our understanding of glioblastoma and driving progress through bold research, innovation and discovery.
Our Approach
Our approach to research is interdisciplinary and collaborative, bringing together experts from different fields to tackle the current challenges we face in treating glioblastoma tumors. We fund projects that have the potential to make a significant impact in patients' lives and support researchers throughout the entire process.
Our Partnerships
At the Glioblastoma Research Society, we believe that collaboration and partnerships are essential to driving progress and advancing scientific research. By bringing together young investigators, research institutions and donors like you, we can continue to accomplish our mission through accelerating the pace of discovery.
Glioblastoma Research Society members
Líza Willey, MSc
Mehdi Touat, MD, PhD
Sylvain Provot, PhD
Líza has been conducting scientific and medical research in academia and industry for almost a decade. She received her Masters of Science in Cell & Molecular Biology at the Sorbonne University in Paris. Her career has spanned the fields of Neuroscience, Stem Cell Biology, Immunoncology and Developmental Biology. While at UCSF, UC Berkeley, Pfizer and Maze Therapeutics, she has helped to advance understanding of many diseases including GBM, Alzheimer's Disease, ALS, Breast Cancer, AML, and Infertility/IVF.
Sylvain Provot, PhD
Mehdi Touat, MD, PhD
Sylvain Provot, PhD
An academic researcher and group leader at the French National Institute of Health and Medical Research (INSERM), Sylvain received his PhD in Cell & Molecular Biology from the Curie Institute in Paris and established his own lab over decade ago. His postdoctoral research was conducted at UCSF and Harvard Medical School, where he was also an instuctor. His work at Lariboisière Hospital focuses on Bone Cancer and the Bone-Brain axis. He was the first to establish the affect osteoblasts had on tumor growth in Breast Cancer.
Mehdi Touat, MD, PhD
Mehdi Touat, MD, PhD
Mehdi Touat, MD, PhD
Dr. Mehdi Touat is a leading physician-scientist dedicated to advancing brain tumor research since 2015. Since receiving his PhD in Experimental Neuro-oncology from Université Pierre et Marie Curie, he heads a research team at the Paris Brain Institute and works in Drug Development at Gustave Roussy Cancer Center. Dr. Touat's expertise in brain tumor genetics, personalized medicine, and overcoming treatment resistance in aggressive cancers like glioblastoma, helps to translate scientific discoveries into better patient outcomes.
Help Our Cause
Your donation will directly help us advance brain cancer research and bring us closer to finding solutions to some of its biggest challenges. Help us today! (501(c)(3) status has been granted by the US IRS and all donations and gifts are tax-exempt)